Search for: "Lange v. Andrews" Results 41 - 60 of 127
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Jul 2023, 1:37 am by Laurence Lai (Simmons & Simmons LLP)
  Indicated entitlement to be a UPC representative   More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eighth Edition by Sally Shorthose€ 265 … [read post]
The judgment is also interesting because it is the first time the court has really focused on the question of interest on past licensing fees (interest on past licensing fees is in issue in InterDigital v Lenovo, but the question of whether it is payable and in what amount was adjourned to a later hearing). [read post]
29 May 2023, 11:43 am by Kluwer Patent blogger
These provisions, placed today in Chapter V of the UPCA, include the definition of the patent’s owner prerogatives to prevent the direct and indirect use of the invention (Art. 25 and 26), the list of limitations concerning the scope of patent protection, including inter alia, acts done privately or for experimental purposes, the use of biological material for the purpose of breeding, discovering and developing other plant varieties (Art. 27), the condition of the right for prior use… [read post]
More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eighth Edition by Sally Shorthose€ 265 The Digital Economy and International Trade:… [read post]
11 May 2023, 2:21 am by Aida Tohala (Bristows)
On 4 May 2023, a mere two weeks after the conclusion of the hearing, the Court of Appeal handed down its decision in Sandoz and Teva v BMS. [read post]
In an earlier post I explained the issues that the proposed EU Regulation on SEPs intends to address, and why neither the market nor the courts solve them. [read post]
The only contentions of error the inventor made were issues of claim construction, which he forfeited by not raising them at the appropriate time during the inter partes review proceeding (Driessen v. [read post]
27 Apr 2023, 9:22 am by Miquel Montañá (Clifford Chance)
In this regard, in its judgment of 12 December 2013 (case C-493/12, Eli Lilly v Human Genome Sciences), the CJEU made the following observations: “30. [read post]
It is superfluous for cases such as Ericsson v Apple, costly and lengthy for the litigants, and clogs the court system. [read post]
8 Apr 2023, 3:50 am by Bart van Wezenbeek (Hoffmann Eitle)
More from our authors: Vissers Annotated European Patent Convention 2022 Edition by Kaisa Suominen, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eighth Edition by Sally Shorthose€ 265 The Digital Economy and International Trade: Transnational Data… [read post]
The judge reviewed the national case law on selections/deletions from multiple lists (Merck v Shionogi [2016] EWHC 2989 (Pat), Nokia v IPCom [2012] EWCA Civ 567 and GlaxoSmithKline v Wyeth [2016] EWHC 1045 (Pat)) and the EPO cases reviewed therein and in the EPO Case Law Book. [read post]
The most famous decision might be the UK Supreme Court’s Ruling in Warner-Lambert Company LLC v Generics (UK) Ltd, which was reported on this blog here. [read post]
27 Mar 2023, 8:18 am by Nicholas Round (Bristows)
On 16 March 2023, the High Court of England and Wales handed down its judgment following the FRAND trial in InterDigital v Lenovo. [read post]
On 16 March 2022, the High Court of England and Wales handed down its judgment following the FRAND trial in InterDigital v Lenovo. [read post]
As an example, it can be a sign of infringement if the marketing strategy induces doctors to prescribe the generic for the omitted therapeutic indication (GlaxoSmithKline v. [read post]
22 Feb 2023, 4:47 am by Brian Cordery (Bristows)
In Optis v Apple, Meade J explained that the date of hand-down itself is not necessarily confidential. [read post]
9 Feb 2023, 7:00 am by Eden Winlow (Bristows)
Nokia v Oppo [2023] EWHC 23 (Pat) In a new development in the global dispute between Nokia and Oppo that spans seven jurisdictions across Europe and Asia, Mr Justice Meade of the English Patents Court has found that smartphone manufacturer Oppo infringes valid and standard essential Nokia 4G/5G patent EP2981103 on an “allocation of preamble sequences”. [read post]
3 Feb 2023, 2:07 am by Kluwer Patent blogger
Less than four months before the launch of the new system, Kluwer IP Law interviewed Véron and asked him how it all started. [read post]
1 Feb 2023, 12:00 am by Jonathan Ross (Bristows)
  In Meadows v Khan and Manchester Building Society v Grant Thornton, the Supreme Court set out a six-part test for determining a damages claim for the tort of negligence. [read post]